Publications by authors named "Sofya N Pchelina"

To date, the molecular mechanisms of the common neurodegenerative disorder Parkinson's disease (PD) are unknown and, as a result, there is no neuroprotective therapy that may stop or slow down the process of neuronal cell death. The aim of the current study was to evaluate the prospects of using the mTOR molecule as a potential target for PD therapy due to the dose-dependent effect of mTOR kinase activity inhibition on cellular parameters associated with, PD pathogenesis. The study used peripheral blood monocyte-derived macrophages and SH-SY5Y neuroblastoma cell line.

View Article and Find Full Text PDF

Obesity is a risk factor for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Adipose tissue (AT) extracellular vesicles (EVs) could play a role in obesity and T2DM associated CVD progression via the influence of their specific cargo on gene expression in recipient cells. The aim of this work was to evaluate the effects of AT EVs of patients with obesity with/without T2DM on reverse cholesterol transport (RCT)-related gene expression in human monocyte-derived macrophages (MDMs) from healthy donors.

View Article and Find Full Text PDF

Obesity is a significant risk factor for the development of type 2 diabetes mellitus (T2DM). Adipose tissue dysfunction can affect the pool of circulating exosomal miRNAs, driving concomitant disease in obesity. These exosomal miRNAs can reflect adipose tissue functionality, thus serving as prognostic biomarkers for disease monitoring in case of T2DM.

View Article and Find Full Text PDF

Here, we report the pediatric cases of sitosterolemia, a rare autosomal-recessive genetic disorder, characterized by high concentrations of plant sterols in blood and heterogeneity manifestations. All three patients (two girls aged 2 and 6 years old, and one boy aged 14 years old) were initially diagnosed with hypercholesterinemia. Next-generation sequencing (NGS) revealed homozygous (p.

View Article and Find Full Text PDF

Mutations in the gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), cause Gaucher disease (GD) and are the most common genetic risk factor for Parkinson's disease (PD). Pharmacological chaperones (PCs) are being developed as an alternative treatment approach for GD and PD. To date, NCGC00241607 (NCGC607) is one of the most promising PCs.

View Article and Find Full Text PDF
Article Synopsis
  • Extracellular vesicles (EVs) are membrane-bound structures derived from cells that facilitate communication and transport various biological materials like proteins and RNAs between cells.
  • Adipose tissue EVs are linked to regulating metabolism and inflammation, playing a role in obesity-related conditions, such as insulin resistance and type 2 diabetes mellitus (T2DM).
  • This study characterizes EVs from visceral and subcutaneous fat in obese T2DM patients, revealing distinct morphological features and compositions that suggest altered EV production in these conditions compared to control groups.
View Article and Find Full Text PDF

Background: Recent studies have focused on the potential role of epicardial adipose tissue (EAT) in the development of coronary artery disease (CAD). ABCA1 and ABCG1 transporters regulate cell cholesterol content and reverse cholesterol transport. We aimed to determine whether DNA methylation and mRNA levels of the ABCA1 and ABCG1 genes in EAT and subcutaneous adipose tissue (SAT) were associated with CAD.

View Article and Find Full Text PDF

Omentin-1 and fatty acid-binding protein 4 (FABP4) are adipose tissue adipokines linked to obesity-associated cardiovascular complications. The aim of this study was to investigate epicardial adipose tissue (EAT) omentin-1 and FABP4 gene expression in obese and non-obese patients with coronary artery disease (CAD). Omentin-1 and FABP4 mRNA levels in EAT and paired subcutaneous adipose tissue (SAT) as well as adipokine serum concentrations were assessed in 77 individuals (61 with CAD; 16 without CAD (NCAD)).

View Article and Find Full Text PDF

Familial hypercholesterolemia (FH) is caused by mutations in various genes, including the , and genes; however, the spectrum of these mutations in Russian individuals has not been fully investigated. In the present study, mutation screening was performed on the gene and other FH-associated genes in patients with definite or possible FH, using next-generation sequencing. In total, 59 unrelated patients were recruited and sorted into two separate groups depending on their age: Adult (n=31; median age, 49; age range, 23-70) and children/adolescent (n=28; median age, 11; age range, 2-21).

View Article and Find Full Text PDF

Common variants and risk factors related to familial and sporadic cases of Parkinson's disease (PD) in diverse populations have been identified at numerous genomic loci. In this study, genetic analysis was performed through a screening of LRRK2 G2019S, GBA mutations (L444P, N370S), and common variants (E326K, T369M) in 762 PD patients and in 400 controls. Next-generation sequencing analysis of 22 PD-related genes in 28 early-onset PD cases from North-Western region of Russia was performed.

View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) often has monogenic forms that are rare, making it challenging to identify mutations, particularly in unrelated patients due to the late onset of the disease.
  • The study analyzed 48 unrelated patients with suspected autosomal dominant PD using whole-exome sequencing (WES) and employed various bioinformatics tools to narrow down potential pathogenic variants.
  • Ultimately, the analysis reduced candidate variants from 7082 to 25 significant ones across 23 genes related to PD, highlighting the importance of further experimental verification for the findings.
View Article and Find Full Text PDF
Article Synopsis
  • * A study in Northwestern Russia analyzed 208 PD patients and found the mutation more frequently in familial cases (3.9%) than in sporadic cases (0.6%).
  • * The mutation was exclusively identified among individuals of Ashkenazi Jewish descent, and was absent in the control group of 161 people without neurological disorders.
View Article and Find Full Text PDF